Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blinded, parallel, placebo-controlled, phase I/IIa
clinical trial of YYD302 for treatment of osteoarthritis of the knee.